Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Transcripts
    • AGM Invitations
  • inderesTV
  • Forum
  • About Us
    • Our Coverage
    • Team

You seem to be using a wider screen, would you like to enable a wider viewing experience on this page?

Life Science Companies as Investments | Life Science Night Dec. 2, 2024

By Inderes

Antti Siltanen, Life Science Analyst, PhD, talks about life science companies as investments.

Life Science Night
Keynote – Antti Siltanen, Inderes (link)
Aiforia – Jukka Tapaninen, CEO (link)
Herantis Pharma – Antti Vuolanto, CEO (link)
Faron Pharmaceuticals – Juho Jalkanen, CEO (link)

Life Science Night December 2, 2024 (link)
Health Technology & Pharmaceutical Developer Night December 11, 2023 (link)
Health Technology & Pharmaceutical Developer Night December 13, 2022 (link)

Stay up to date
Aiforia Technologies
BBS-Bioactive Bone Substitutes
Bioretec
Biohit
Faron Pharmaceuticals
Modulight
Nexstim
Orion
Bittium
Detection Technology
Optomed
Revenio Group
Nightingale Health
Herantis Pharma
Nanoform Finland
Investor events

Recent videos

HCA Morgenbørs 13/03 - Afventende markeder op til weekenden
13.03.2026, 11.53 DSV
Rapala H2'25: North American sales a highlight of the end of the year
12.03.2026, 16.25 Rapala VMC
Columbus – Presentation of Annual Report 2025
12.03.2026, 13.00 Columbus
Tokmanni Q4’25: Dollarstore’s turnaround is stalling
12.03.2026, 12.02 Tokmanni Group
Multitude, Webcast, Q4'25
12.03.2026, 10.00 Multitude
View all videos
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.